Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1000 MBQ/ML) IV SOLN (CDM RX-186947) by Hospital .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 20, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-186947/by-hospital?code_type=CDM
“LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1000 MBQ/ML) IV SOLN (CDM RX-186947) by Hospital.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-186947/by-hospital?code_type=CDM. Accessed
November 20, 2026 .
“LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1000 MBQ/ML) IV SOLN (CDM RX-186947) by Hospital,” HANK Price Transparency ,
accessed November 20, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-186947/by-hospital?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across hospitals
RX-186947 — Lutetium Lu-177 Vipivotide Tetraxetan 27 Mci/ml (1000 Mbq/ml) IV Soln
Hospital-by-hospital median negotiated rates.
Hospitals are ranked by their typical (median) negotiated rate (highest first by default; click a column to re-sort). Outliers are flagged
where a hospital's median is more than 2× or less than 0.5× the
cohort median (red = high, green = low).
$63,290
National median
$65,098
Cohort median
4
hospitals
1
states (national)
Rank hospitals by my cost →
Outliers
↑ 0 high
↓ 0 low
out of 4 hospitals
Median negotiated rate, by hospital
Ranked by typical (median) negotiated price. Red = high outlier, green = low outlier, slate = in-range.
Hover for IQR.
Median negotiated rate by hospital for RX-186947 (CDM)
Hospital State Median p25 p75 Outlier flag
Infirmary Ltac Hospital AL $90,414 $76,852 $90,414 in range
THOMAS HOSPITAL AL $65,098 $63,290 $67,810 in range
MOBILE INFIRMARY MEDICAL CENTER AL $63,290 $50,636 $67,810 in range
NORTH BALDWIN INFIRMARY AL $63,290 $50,636 $76,852 in range